Glenmark
Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India
Jaipur, January 04, 2024. Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, has launched a biosimilar of the popular10,11 anti-diabetic… Read More